Top 10 India Pharma Manufacturers CDMOs 2026
With 350+ USFDA-registered facilities and 30-40% lower costs, these are the Indian CDMOs capturing China+1 diversification demand in 2026. India
Read More
Pharmacta
Industry Intelligence
Latest:
- The GLP-1 Access Paradox: Policy Wins, But 48 Million Americans Still Can’t Afford Them
- The Hospital Pharmacy Visibility Crisis: 80% Lack Real-Time Supply Chain Insight
- BioNTech’s mRNA Cancer Vaccine Failure: What Colorectal Cancer Teaches About Immunotherapy’s Limits
- Takeda Just Broke a 40-Year Treatment Drought for Rare Blood Cancer—And It’s About to Transform Patient Lives
- FDA Just Approved Mounjaro for Heart Protection—Here’s Why This Changes Diabetes Treatment Forever
Manufacturing
Daily intelligence on pharma manufacturing — CDMO and contract manufacturing moves, GMP compliance and FDA warning letters, facility investment, and production capacity across the global pharmaceutical supply chain.
Top 10 UK & EU Pharma Manufacturers CDMOs 2026
With 74% of Europe’s APIs still sourced from Asia, these are the UK and EU CDMOs positioned to capture reshoring
Read More
Top 10 US Pharma Manufacturers CDMOs Ranked 2026
The US CDMO market is racing past $39 billion as sponsors reshore from China — here’s who actually has the
Read More